Replies to post #122224 on Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

most don't, but in our case, I'm not so certain that your understanding is correct

telling prospective investors that you'd be buying all you can under $0.08 while knowing full well you are about to steer the company into a full tilt vertical nose dive of floorless convertibles - is suspect at best...

AJMHO

[christjamin]

You got that right. Just watch, the same people who are whining, smearing GC, doubting him will soon be on the opposite side: praising GC and Ambs once pps starts turning north. Many don't have no conviction whatsoever. The only thing that motivates their writing is their position. So I take their posts as noise. 1 in 10 drugs at phase 1 trial makes it to finish line. Who is going to put money, his/her hard money on these tiny biotech ? Avx* went from $5 to $.15 cents before starting the run. Then afyer split and uplist, their shares count skyricket from 11 millions to 34 in less than 3 months, for financing..GB*n went from $6 dollars to 10 cents.. Once piepline gets close to maturity or drug close to approval companies get more clean financing..Pphm and ctic, Acad and so forth just financed through shares sales.. forth just financed through shares sales through shares sales.